trending Market Intelligence /marketintelligence/en/news-insights/trending/5BvLYF3LioAfNskTIkrmSQ2 content esgSubNav
In This List

Cell MedX CEO resigns; replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cell MedX CEO resigns; replacement named

Cell MedX Corp. said Frank McEnulty resigned as the company's CEO but will continue to serve on the company's board.

Terrance Owen will replace McEnulty as CEO. Owen was also appointed to Cell MedX's board of directors.

Owen was previously CEO of Champion Pain Care Corp.